Reality check5 Jun 2026 09:38
As a former investor and employee I'm stepping away from NCYT.
The capable PCR company you invested in is now called YouSeq and the former team have a "crazy enough system that it might just work" whereby they make more money than it costs to run a company while making some of the most sensitive and specific PCR tests you can spend money on. They'll be leveraging their capability to react to Ebola or the next problem round the corner. What is left at NCYT is not that.
The niche carving, ground breaking instrumentation company you invested in is gone. Engineers and capability of a David vs Goliath, globally recognised instrumentation company gone to the wind. What is left is not that.
What is lift is a genomic medicine company with a side line in me-too PCR tests. While they're a recognised player they're not market leaders in any segment and even with a reduction in head count they won't be profitable. Their niche doesn't support it.
But stop, ask yourself if you'd invest in Novacyt today. You have 50k and this is your best option? If you would then by all means carry on and I wish you all the best. Will the company be involved in a market where it will grow by two orders of magnitude or more? No, They aren't agile enough to respond to the market quickly enough even if god forbid something on the scale of covid happened again.
Very much do your own research and my opinion is my own. This message group is like a loss porn reddit thread and now I've sold I'll not be coming back. I suggest a few other could do with the same. I'll say it again though, for a lot of people in this thread, the company you invested in isn't there anymore. For the recent investors who are riding the peaks and troughs around 40p, this is volatile enough that you might make a return.
It reminds me of Arthurs conversation with Zaphod in H2G2. Arthur asks "How do they sell the peril sensitive glasses at a loss?" and Zaphod replies "He sells a lot of them..."
Sign In
Follow the stocks
